Hyderabad Hospital Ex-CEO Sold Assets for Drugs, Say Cops

Cyberabad police arrested the former CEO of a prominent corporate hospital in Mumbai, caught with 53 grams of cocaine, who was heavily addicted to drugs.

India May Face Drug Price Hikes after Trump Policy Shift

U.S. President Donald Trump’s latest administrative order pointing to cut domestic drug prices could wave across global pharmaceutical markets, with certain pressure on India to raise prices.

Emcutix in Collaboration with Canada-based Mantra Pharma Launch UREADERM

Emcutix Biopharmaceuticals Ltd., in collaboration with Canada-based Mantra Pharma Inc. – both subsidiaries of Emcure Pharmaceuticals Ltd. – has announced the pan-India launch of Ureaderm 10 percent & 20 percent, a urea-based moisturizer in cream

India Eyes Kuwait Pharma Market Amid Growing Import Demand

India Eyes Kuwait Pharma Market Amid Growing Import DemandIn a bid to tap into increasing pharmaceutical demand in Kuwait, the Indian Pharmaceuticals Export Promotion Council of India (Pharmexcil) is seeking comments from Indian pharma...

Indian Pharma Giants Brace for Impact Amid U.S. Drug Price Shake-Up

India’s pharmaceutical sector is feeling the heat after U.S. President Donald Trump unveiled a bold plan to cut drug prices by 30-80%. This policy, aimed at making U.S. drug costs match lower prices in other countries, could shake up the 9 billio...

Solara Active Pharma's Ambernath Plant Clears USFDA Check

Solara Active Pharma Sciences reported that its Ambernath facility in Maharashtra, having multiple products manufacturing, passed inspection by the United States Food and Drug Administration (USFDA)...

Export Ban to Pakistan Won't Impact Himachal's Pharma Sector

The Centre's latest move to impose a ban on the export of pharmaceuticals to Pakistan, after the April 22 terror attack in Pahalgam, which killed 26 people, will have negligible or no effect on Himachal Pradesh's pharmaceutical industry...

DTAB approves Sub-committee Report Suggesting Prohibition of 16 FDCs

A report from the Drugs Technical Advisory Board's (DTAB) subcommittee, led by Dr. Nilima Kshirsagar, found 16 fixed dose combinations (FDCs) to be irrational and suggested that they be banned because they could endanger human health. The DTAB concur

DCA Raids in Telangana Uncover Banned, Expired Drugs in Hospitals

During a massive crackdown across Telangana, Drug Control Administration (DCA) officials raided 66 pharmacies linked to corporate hospitals; they found a mass violation of regulations including sale of...

Senores Pharmaceuticals Acquires USFDA-Approved ANDA for Tramadol Tablets

Senores Pharmaceuticals Limited, a world class research based pharmaceutical firm has made a disclosure that its 100% owned subsidiary...

© 2025 India Pharma Outlook. All Rights Reserved.